glp 1 agonist in pregnancy GLP-1 receptor agonists are increasingly used before pregnancy, but safety data have been limited., This meta-analysis pooled data from nearly 37,000 pregnancies and found no increased risk of major GLP-1s (Weight loss injections) AND

Description

The randomized, double-blind, placebo-controlled study tested various doses of Danuglipron against a placebo over 16 weeks

Moreover, the SURPASS programme demonstrated that tirzepatide 15 mg is more efficacious in glycaemic control for people with T2D compared to insulin therapies as well as GLP-1 mono-agonists including semaglutide 1 mg and dulaglutide 1.5 mg

While both drug classes demonstrate efficacy in metabolic parameters, their distinct mechanisms offer unique therapeutic advantages

Experts say the results point to the notion that the drug should continue to be used as directed, with close consultation from medical professionals.

Designing small molecules able to target multiple receptors might sound difficult, but Septerna says the allosteric binding site it has discovered is even better conserved across all incretin receptors than the site targeted by peptides and other small molecule drugs